000			02309 a2200649 4500
005			20250518014521.0
264		0	_c20200720
008			202007s 0 0 eng d
022			_a1549-490X
024	7		_a10.1634/theoncologist.2018-0243 _2doi
040			_aNLM _beng _cNLM
100	1		_aPietri, Elisabetta
245	0	0	_aPhase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer. _h[electronic resource]
260			_bThe oncologist _c06 2019
300			_a743-e205 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aAromatase Inhibitors _xadministration & dosage
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aDehydroepiandrosterone _xadministration & dosage
650	0	4	_aDisease Progression
650	0	4	_aDrug-Related Side Effects and Adverse Reactions _xepidemiology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aProspective Studies
650	0	4	_aReceptors, Androgen _xmetabolism
650	0	4	_aReceptors, Estrogen _xmetabolism
650	0	4	_aResponse Evaluation Criteria in Solid Tumors
650	0	4	_aSurvival Analysis
650	0	4	_aTime Factors
650	0	4	_aTriple Negative Breast Neoplasms _xdrug therapy
700	1		_aMassa, Ilaria
700	1		_aBravaccini, Sara
700	1		_aRavaioli, Sara
700	1		_aTumedei, Maria Maddalena
700	1		_aPetracci, Elisabetta
700	1		_aDonati, Caterina
700	1		_aSchirone, Alessio
700	1		_aPiacentini, Federico
700	1		_aGianni, Lorenzo
700	1		_aNicolini, Mario
700	1		_aCampadelli, Enrico
700	1		_aGennari, Alessandra
700	1		_aSaba, Alessandro
700	1		_aCampi, Beatrice
700	1		_aValmorri, Linda
700	1		_aAndreis, Daniele
700	1		_aFabbri, Francesco
700	1		_aAmadori, Dino
700	1		_aRocca, Andrea
773	0		_tThe oncologist _gvol. 24 _gno. 6 _gp. 743-e205
856	4	0	_uhttps://doi.org/10.1634/theoncologist.2018-0243 _zAvailable from publisher's website
999			_c29203752 _d29203752